AI system can equal or surpass ophthalmologists in diagnosis, treatment of glaucoma and retina disorders

A large language model (LLM) artificial intelligence (AI) system can match, or in some cases outperform, human ophthalmologists in the diagnosis and treatment of patients with glaucoma and retina disease, according to research from New York Eye and Ear Infirmary of Mount Sinai (NYEE).

Mankind, Innovent partner for Sintilimab commercialisation in India

Under the agreement, Mankind Pharma will have the exclusive rights to register, import, market, sell, and distribute Sintilimab in India. Credit: Piotr Swat/Shutterstock. Mankind Pharma

December 27, 2024

Virgin Pulse Launches Global Loneliness Challenge for Employers

What You Should Know: Virgin Pulse launches a five-week global loneliness challenge for employers and health plans designed to foster social connections and reverse costly

August 16, 2023

Sanofi discontinues Denali-partnered MS trial after Phase 2 failure

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.